e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Preclinical models for the development of new drugs for respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Validation of a hypertussive model of cough in the rabbit
E. Clay, D. Spina, C. Page (London, United Kingdom)
Source:
Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Session:
Preclinical models for the development of new drugs for respiratory diseases
Session type:
Thematic Poster Session
Number:
688
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Clay, D. Spina, C. Page (London, United Kingdom). Validation of a hypertussive model of cough in the rabbit. Eur Respir J 2013; 42: Suppl. 57, 688
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
A 41-year-old male with cough productive of yellow sputum and worsening breathlessness
Related content which might interest you:
Characterisation of a steroid-insensitive severe asthma model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Standardization of a murine model of asthma due to soybean inhalation
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
Adjuvant-free mouse model of allergic asthma
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
A new model for analysis of chronic bronchial interleukin-8 expression
Source: International Congress 2016 – Airway response to infection
Year: 2016
Targeting IL33-ST2 pathway in virus-induced exacerbation of experimental asthma
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Transient receptor potential channels in a mouse model of isocyanate-induced airway hyperresponsiveness
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
Cough and expiratory reflex during growth in young rabbits
Source: International Congress 2014 – Respiratory physiology and sleep disordered breathing in children
Year: 2014
Developing a chronic murine model that better reflects the clinical features of the human asthma
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Metabolomic profiling of the lung in a murine model of emphysema
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
RIG-I receptors induced by dsRNA challenges in an HDM-mouse model of asthma exacerbation
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014
Development of a lung slice methodology to study the mechanisms of lung uptake and lysosomal trapping
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
The effect of different PV extracts in the treatment of asthma in an animal model
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
The role of lL-17 in the OVA-LPS driven model of lung inflammation
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Effect of diminazene on monocrotalin-induced pulmonary hypertension rat model
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Characterization of an endogenous Th17-cell generation during sensitization in the murine lung
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Study of the trachea after teflon injection
Source: Annual Congress 2013 –Therapeutical bronchoscopy for treatment of airway disorders: laser, stents and more
Year: 2013
IL-13 in a mouse model of chemical-induced airway hyperresponsiveness
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
A compare between two models of cigarette smoke co-exposition in ovalbumin-sensitized mice
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept